Natural Occurrence of Aldol Condensation Products in Valencia Orange Oil by Abreu, Ingo, Da Costa, Neil C., Es, Alfred, Kim, Jung‐A, Parasar, Uma, Poulsen, Mauricio L.

Get full text

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials by Moran, Antoinette, Prof, Bundy, Brian, PhD, Becker, Dorothy J, Prof, DiMeglio, Linda A, MD, Gitelman, Stephen E, Prof, Goland, Robin, Prof, Greenbaum, Carla J, MD, Herold, Kevan C, Prof, Marks, Jennifer B, Prof, Raskin, Philip, Prof, Sanda, Srinath, MD, Schatz, Desmond, Prof, Wherrett, Diane K, MD, Wilson, Darrell M, Prof, Krischer, Jeffrey P, Prof, Skyler, Jay S, Prof, Pickersgill, Linda, MD, de Koning, Eelco, Prof, Ziegler, Anette-G, Prof, Böehm, Bernhard, Prof, Badenhoop, Klaus, Prof, Schloot, Nanette, MD, Bak, Jens Friis, MD, Pozzilli, Paolo, Prof, Mauricio, Didac, MD, Donath, Marc Y, Prof, Castaño, Luis, Prof, Wägner, Ana, MD, Lervang, Hans Henrik, MD, Perrild, Hans, MD, Mandrup-Poulsen, Thomas, Prof

Get full text

Interleukin‐1 antagonism moderates the inflammatory state associated with Type 1 diabetes during clinical trials conducted at disease onset by Cabrera, Susanne M., Wang, Xujing, Chen, Yi‐Guang, Jia, Shuang, Kaldunski, Mary L., Greenbaum, Carla J., Mandrup‐Poulsen, Thomas, Hessner, Martin J.

Get full text

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes by Gale, Edwin AM

Get full text

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial : the role of additional immune, genetic and metab... by BINGLEY, P. J, GALE, E. A. M

Get full text

Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives by Achenbach, P, Bonifacio, E, Williams, A J K, Ziegler, A G, Gale, E A M, Bingley, P J

Get full text